IRIS
Paciotti, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.480
NA - Nord America 1.080
SA - Sud America 685
EU - Europa 338
AF - Africa 54
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.644
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.026
SG - Singapore 871
BR - Brasile 549
CN - Cina 234
VN - Vietnam 229
AR - Argentina 67
IT - Italia 55
FI - Finlandia 51
IE - Irlanda 40
DE - Germania 39
HK - Hong Kong 32
GB - Regno Unito 30
EC - Ecuador 25
ID - Indonesia 24
MX - Messico 23
FR - Francia 21
IN - India 21
NG - Nigeria 21
BD - Bangladesh 19
CA - Canada 19
RU - Federazione Russa 16
NL - Olanda 13
ZA - Sudafrica 13
UA - Ucraina 12
AT - Austria 10
CO - Colombia 10
IQ - Iraq 10
SE - Svezia 10
PY - Paraguay 9
UY - Uruguay 8
CL - Cile 7
PK - Pakistan 7
PL - Polonia 7
TR - Turchia 7
VE - Venezuela 7
AU - Australia 6
CH - Svizzera 6
TN - Tunisia 6
UZ - Uzbekistan 5
BE - Belgio 4
DO - Repubblica Dominicana 4
EG - Egitto 4
JP - Giappone 4
ES - Italia 3
IL - Israele 3
JM - Giamaica 3
KE - Kenya 3
KZ - Kazakistan 3
PE - Perù 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AZ - Azerbaigian 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
GR - Grecia 2
GT - Guatemala 2
LT - Lituania 2
NP - Nepal 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
CI - Costa d'Avorio 1
GA - Gabon 1
GD - Grenada 1
HU - Ungheria 1
LB - Libano 1
MA - Marocco 1
MY - Malesia 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
SA - Arabia Saudita 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.644
Salva come PNG Salva come JPEG
Città #
Singapore 175
Dallas 158
The Dalles 112
Beijing 98
Ashburn 94
Ho Chi Minh City 88
Shanghai 73
Wilmington 73
Chandler 62
Helsinki 51
Hanoi 45
New York 42
Dublin 40
San Mateo 39
São Paulo 35
Ann Arbor 31
Boardman 29
Hong Kong 28
Milan 28
Los Angeles 25
Lawrence 24
Princeton 24
Rio de Janeiro 23
Benin City 21
Paris 18
Leawood 16
Camden 12
Da Nang 11
Guayaquil 11
Haiphong 11
Thái Bình 10
Fairfield 9
Mexico City 9
Seattle 9
Amsterdam 8
Belo Horizonte 8
Brasília 8
Brooklyn 8
Orem 8
Porto Alegre 8
Buenos Aires 7
Curitiba 7
Goiânia 7
Hải Dương 7
London 7
Manaus 7
Quito 7
Toronto 7
Warsaw 7
Biên Hòa 6
Johannesburg 6
Montevideo 6
Osasco 6
Phoenix 6
Salvador 6
Woodbridge 6
Asunción 5
Campinas 5
Council Bluffs 5
Feira de Santana 5
Hortolândia 5
Lausanne 5
Montreal 5
Naples 5
Nuremberg 5
Santa Clara 5
São Gonçalo 5
São José do Rio Preto 5
Tashkent 5
Uberlândia 5
Balasore 4
Caxias do Sul 4
Guarulhos 4
Istanbul 4
Jakarta 4
Juiz de Fora 4
Londrina 4
Mogi das Cruzes 4
Moscow 4
New Haven 4
Ninh Bình 4
Resistencia 4
San Diego 4
Secaucus 4
Tunis 4
Amstelveen 3
Bauru 3
Belford Roxo 3
Brussels 3
Bình Dương 3
Cape Town 3
Córdoba 3
Duque de Caxias 3
Erbil 3
Formosa 3
Guarujá 3
Ha Long 3
Itaquaquecetuba 3
Lima 3
Lấp Vò 3
Totale 1.862
Salva come PNG Salva come JPEG
Nome #
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project 97
Xpert Bladder Cancer Detection in Emergency Setting Assessment (XESA Project): A Prospective, Single-centre Trial 69
Impact of prostate cancer screening in European ancestry un‐affected men with germline DNA repair pathogenic variants 67
Ex Vivo Real-time Assessment of Detrusor Muscle Sampling via Confocal Microscopy During Endoscopic Resection of Bladder Tumor 66
XPERTBLADDER MONITOR TEST FOR FAILURE DEFINITION OF PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) WITH NEGATIVE CITOLOGY 66
p2PSA for predicting biochemical recurrence of prostate cancer earlier than total prostate-specific antigen after radical prostatectomy: an observational prospective cohort study 65
UP-DATE OF PATHOLOGICAL OUTCOME AND SUBJECTIVE DEFINITION OF FAILURE FOR PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER: RESULT FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT 65
Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: Pure versus non-pure CIS 63
DIAGNOSTIC ACCURACY OF TARGETED PROSTATE BIOPSIES: RESULTS FROM A PROSPECTIVE TRIAL COMPARING MICRO-ULTRASOUND WITH MULTIPARAMETRIC MRI FOR THE DETECTION OF PROSTATE CANCER 61
Comparison of micro-ultrasound and multiparametric magnetic resonance imaging for prostate cancer: A multicenter, prospective analysis 59
Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non-muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) Experience 59
Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer 59
Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study 57
Optimizing Prostate Cancer Diagnostic Work‐Up Through Micro‐Ultrasound: Minimizing Unnecessary Procedures and Reducing Overdiagnoses 56
Assessing the Feasibility and Accuracy of High-resolution Microultrasound Imaging for Bladder Cancer Detection and Staging 55
IN VITRO AND IN VIVO NEW EVIDENCE FOR FLEXOR VUE DEFLECTING ENDOSCOPIC SYSTEM USE: OPTIMIZATION OF THE STONE FREE RATE (SFR) AFTER RIRS 49
Long-term Follow-up After En Bloc Transurethral Resection of Non-muscle-invasive Bladder Cancer: Results from a Single-center Experience 49
Atlas of Intracorporeal Orthotopic Neobladder Techniques After Robot-assisted Radical Cystectomy and Systematic Review of Clinical Outcomes 48
Gender-specific risk factors for renal cell carcinoma: a systematic review 48
Comparison of the Diagnostic Accuracy of Micro-ultrasound and Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies for the Diagnosis of Clinically Significant Prostate Cancer 47
The relationship between hospital volume and outcomes of radical prostatectomy: a new perspective on an old story 47
External Validation and Comparison of Two Nomograms Predicting the Probability of Lymph Node Involvement in Patients subjected to Robot-Assisted Radical Prostatectomy and Concomitant Lymph Node Dissection: A Single Tertiary Center Experience in the MRI-Era 46
ROBOT-ASSISTED PARTIAL NEPHRECTOMY: TECHNIQUES AND OUTCOMES FROM THE TRANSATLANTIC ROBOTIC NEPHRON-SPARING SURGERY (TRONES) STUDY GROUP 46
Active surveillance for recurrent non-muscle invasive bladder cancer: which lessons have we learned during COVID-19 pandemic? 46
En bloc re-resection of high-risk NMIBC after en bloc resection: results of a multicenter observational study 45
Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional study 44
Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective Study 42
Effects of a home-based pelvic floor muscle training with and without action and cue observation on urinary incontinence after prostatectomy: A randomized controlled trial 41
Impact of high-intensity local treatment on overall survival in stage IV upper tract urothelial carcinoma 41
A Comparative Evaluation of Multiparametric Magnetic Resonance Imaging and Micro-Ultrasound for the Detection of Clinically Significant Prostate Cancer in Patients with Prior Negative Biopsies 40
Systematic Review of Time to Definitive Treatment for Intermediate Risk and High Risk Prostate Cancer: Are Delays Associated with Worse Outcomes? 40
Systematic Review and Clinical Outcomes of new Robotic Systems in Urology 39
Reliability of the da Vinci robotic surgical system: a systematic review and pooled analysis of technical failures 38
Assessing the diagnostic accuracy of micro-ultrasound for the detection of clinically significant prostate cancer in the initial biopsy setting 36
Midterm follow-up (3 years) confirms and extends short-term results of intravesical gemcitabine as bladder-preserving treatment for non-muscle-invasive bladder cancer after BCG failure 36
Assessment of the diagnostic accuracy of microultrasound for the detection of clinically significant prostate cancer: Results from a single-institutional preliminary experience 35
Diagnostic accuracy of multiparametric MRI- and microultrasound-targeted biopsy in biopsy-naïve patients with a PI-RADS 5 lesion: a single-institutional study 34
An Evaluation of the Diagnostic Accuracy of [68Ga]Ga-PSMA-11 vs. [18F]F-PSMA-1007 PET/CT for Lymph Node Staging in Patient Candidates for Radical Prostatectomy and Lymph Node Dissection: A Single Institutional Analysis 34
The use of 29 MHz transrectal micro-ultrasound to stratify the prostate cancer risk in patients with PI-RADS III lesions at multiparametric MRI: A single institutional analysis 34
Assessing the relationship between micro-ultrasound results and pathology at radical prostatectomy 34
Male awareness of prostate cancer risk remains poor in relatives of women with germline variants in DNA-repair genes 34
A cost analysis in implementing simulation-based training into a novel urology curriculum 33
Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial 33
THE UTILITY OF MICRO-ULTRASOUND IN PATIENTS UNDER ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER: A PRIAS STUDY EXTENSION 33
Reply by Authors 31
A Propensity Score–matched Comparison of Micro-ultrasound–guided Transrectal and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion-guided Transperineal Prostate Biopsies for Detection of Clinically Significant Prostate Cancer 31
Assessing the Role of High-resolution Microultrasound Among Naïve Patients with Negative Multiparametric Magnetic Resonance Imaging and a Persistently High Suspicion of Prostate Cancer 31
Assessing long‐term upgrade risks in recurrent low‐grade non‐muscle‐invasive bladder cancer, can we deintensify the treatment? 31
Diagnostic performance of microUltrasound at MRI-guided confirmatory biopsy in patients under active surveillance for low-risk prostate cancer 30
Where Do Micro-Ultrasound and MRI Find Prostate Cancer? A Target Localization Study 30
Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers 29
Enhanced diagnostic accuracy of micro-ultrasound in prostate cancer detection: An updated series from a single-center prospective study 28
A nomogram to predict pathologic T2 stage in candidates to robot-assisted radical prostatectomy with iT3 prostate cancer on preoperative multiparametric MRI: results from a multi-institutional collaboration 28
Assessing the diagnostic accuracy of micro-ultrasound for the detection of clinically significant prostate cancer: Results from a single-institutional experience 28
High resolution micro-ultrasound imaging for bladder cancer: A gender and stage-oriented assessment. VIDEO 27
Diagnostic performance of micro-ultrasound in patients under active surveillance for low-risk prostate cancer 27
Impact of a structured rehabilitation program on urinary continence in patients with intermediate high-risk prostate cancer undergoing robotic-assisted laparoscopic prostatectomy 27
Comparative analysis of robot-assisted simple prostatectomy: the HUGO™ RAS system versus the DaVinci® Xi system 27
Diagnostic performance of micro-ultrasound in a contemporary cohort of patients in active surveillance for localized prostate cancer: A single-institutional experience 27
Transforming hostile abdomen management: the rise of single-port for retroperitoneal robot-assisted partial nephrectomy 27
Will Renorrhaphy Become Obsolete? Evaluation of a New Hemostatic Sealant 26
Surgical Complications Requiring Intervention in Open versus Minimally Invasive Radical Prostatectomy 26
Assessment of face and content validity of performance metrics for basic robotic surgery skills PBP curriculum: a J-ERUS/YAU consensus on dry-lab training models 26
Profiling of the immune microenvironment in prostate cancer at single cell level 26
Beyond the price tag: reassessing the value of robotic surgery in urologic oncology 26
New horizons in gynecological surgery: first-year experience with HUGO™ robotic-assisted surgery system at two tertiary referral robotic centers 26
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 25
The effect of lymph node dissection on oncological outcomes in contemporary robotic salvage radical prostatectomy patients: a junior ERUS/YAU collaborative study 25
Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic 25
Impact of Mayo Adhesive Probability score and BMI on renal functional decline after robotic assisted partial nephrectomy 25
Comparison between the diagnostic accuracy of high resolution micro-ultrasound versus multiparametric MRI in the detection of prostate cancer: Preliminary results from a single-institutional ongoing prospective trial 24
Current Landscape of Surgical Assessment Models in Urology Residency Training. Letter 24
Robot-assisted Radical Prostatectomy Performed with Different Robotic Platforms: First Comparative Evidence Between Da Vinci and HUGO Robot-assisted Surgery Robots 24
Estimating the impact of enhanced care at minority‐serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers 23
International consensus panel for transurethral resection of bladder tumours metrics: assessment of face and content validity 22
HEAD-TO-HEAD COMPARISON BETWEEN MICRO-ULTRASOUND AND MRI IN THE DIFFERENTIATION BETWEEN MUSCLE-INVASIVE AND NON-MUSCLE INVASIVE BLADDER CANCER: RESULTS FROM THE BLADDER MICROUS VERSUS MRI CANCER IMAGING STAGING STUDY (BUS-MISS) PROTOCOL 22
Balancing oncological control and renal function: the emerging role of robotic distal ureterectomy in upper tract urothelial carcinoma 22
MP36-20 POTENTIALS OF 68GA-PROSTATE SPECIFIC MEMBRANE ANTIGEN PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER 22
Temporal Trends in the Incidence of Testicular Cancer in the United States over the Past Four Decades 21
Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride 21
European training in urology (ENTRY): quality-assured training for European urology residents 21
Preoperative Age and Its Impact on Long-Term Renal Functional Decline after Robotic-Assisted Partial Nephrectomy: Insights from a Tertiary Referral Center 21
Temporal Trends and Predictors in the Use of Stereotactic Body Radiotherapy for Treatment of Metastatic Renal Cell Carcinoma in the U.S 21
Robotic assisted vs open radical cystectomy: an updated systematic review and meta-analysis 21
Robot-Assisted Sacropexy with the Novel HUGO Robot-Assisted Surgery System: Initial Experience and Surgical Setup at a Tertiary Referral Robotic Center 20
Outcomes of Robot-assisted Radical Prostatectomy with the Hugo RAS Surgical System: Initial Experience at a High-volume Robotic Center 20
The Natural History of Renal-Cell Carcinoma with Sarcomatoid Differentiation, a Stage-by-Stage Analysis 20
Clinically significant prostate cancer detection rate in biopsy-naïve patients with mpMRI and microultrasound topographically discordant lesions: A single-center retrospective analysis 20
A comparative analysis of the HUGOTM robot-assisted surgery system and the Da Vinci® Xi surgical system for robot-assisted sacrocolpopexy for pelvic organ prolapse treatment 20
Ureteral stricture rate after endoscopic treatments for urolithiasis and related risk factors: systematic review and meta-analysis 19
Risk factors and reasons for reoperation after radical cystectomy 19
Robot-assisted radical prostatectomy feasibility and setting with the Hugo™ robot-assisted surgery system 19
Proficiency-based Progression Training: A Scientific Approach to Learning Surgical Skills 18
Minimally invasive cancer surgery is associated with a lower risk of venous thromboembolic events 18
Robot-assisted adrenalectomy: Step-by-step technique and surgical outcomes at a high-volume robotic center 18
Is multiparametric MRI always needed in biopsy-naïve patients with abnormal digital rectal examination? A single-institutional experience combining clinical and micro-ultrasonography-based factors to optimize prostate cancer detection 18
Improving Augmented Reality Through Deep Learning: Real-time Instrument Delineation in Robotic Renal Surgery 18
Patient‐side performance metrics in robotic surgery: international Delphi‐based consensus from the Junior European Association of Urology Robotic Section/Young Academic Urologists 17
Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non–muscle-invasive Bladder Cancer 17
Propensity Score-Matched Analysis of Radical and Partial Nephrectomy in pT3aN0M0 Renal Cell Carcinoma 17
Totale 3.458
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.997
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021147 0 0 0 0 0 42 23 11 34 19 0 18
2021/2022126 2 9 1 23 0 1 7 17 18 12 33 3
2022/2023283 51 4 28 24 23 16 7 19 37 31 36 7
2023/2024287 22 22 57 10 11 44 17 30 2 8 21 43
2024/2025891 21 2 21 15 4 66 35 48 114 145 130 290
2025/20262.026 460 257 364 663 231 51 0 0 0 0 0 0
Totale 3.780